A team led by Bruce Spiegelman, PhD, has identified both parts of a molecular switch that normally causes some immature muscle cells in the embryo to become brown fat cells.
With this switch in hand, the scientists showed they could manipulate it to force other types of cells in the laboratory to produce brown fat, known as Brown Adipose Tissue (BAT). Their findings are being reported in the journal Nature on its Web site as an advanced online publication on July 29.
The scientists then transplanted these synthetic brown fat precursors, known as eBAT (engineered BAT), into adult mice to augment their innate stores of brown fat. Tests showed that the brown fat transplants were burning caloric energy at a high rate -- energy that otherwise would have been stored as fat in white adipose tissue.
"Since brown fat cells have very high capacity to dissipate excess energy and counteract obesity, eBAT has a very high potential for treating obesity," said Shingo Kajimura, PhD, lead author of the paper. "We are currently working on this."
Excess caloric energy in the diet is stored in white fat calls that pile up in the body, particularly in the thighs and abdomen. The accumulated fat content in overweight people puts stress on these cells, which give out signals that cause inflammation in body organs and the circulatory system, creating risks of heart disease and diabetes.
Brown fat, by contrast, works in an opposite fashion; it evolved to protect animals from cold conditions and prevent obesity. Brown fat cells are equipped with a large supply of mitochondria -- tiny organelles that use oxygen to burn sugar from the diet to generate heat, rather than store the energy as fat.
Scientists have long thought that brown fat was present in young animals and human newborns but virtually absent in human adults. Recently, however, researchers have used modern PET (positron emission tomography) scanners -- which detect tissue that is actively absorbing sugar -- to search for deposits of brown fat in adults. Such experiments have revealed unexpectedly large amounts of brown fat scattered through the neck and chest areas.
In 2007, Spiegelman's team, led by Patrick Seale, PhD, who is the second author of the new Nature paper, discovered a protein, PRDM16, that serves as a switch that determines whether immature muscle cells will develop into mature muscle cells or become brown fat cells.
But this was not the whole story. The scientists suspected that PRDM16 worked with another unknown protein to initiate brown fat development. This proved to be the case. In the new experiments, the Spiegelman group found that PRMD16 works in tandem with the protein C/EBP-beta, and only as a two-part unit are they sufficient to jump-start brown fat development in several types of cells.
To find out if the PRDM16-C/EBP-beta switch could change the identity of other types of cells, forcing them to become brown fat cells, the researchers used viruses to transfer the switch into embryonic mouse connective tissue cells called fibroblasts. They also installed the switch into adult mouse skin cells, and into human skin cells isolated from foreskins removed from newborns during circumcision.
In all three cases, the fibroblasts produced mature brown fat cells. The scientists then transplanted the cells into mice, where they produced brown fat tissue. PET scans confirmed that the new brown fat tissue was burning excess energy in the animals, as they should. The experiments did not test whether the extra brown fat actually protected the mice from becoming obese.
Spiegelman said the results "give a lot more credence" to efforts to manipulate the brown fat switch as a potential means of treating people with obesity and diabetes. One strategy would be to remove some tissue from the patient, add the PRDM16-C/EBP switch, and return it to the patient where it would manufacture additional brown fat.
A more conventional possibility would be to administer a drug to the patient that would ramp up the production of brown fat without the need for a transplant, said Spiegelman, who is also a professor of cell biology at Harvard Medical School. "If we can find a hormone that does that, it's reasonable to think that it might provide a direct anti-obesity treatment."
Other authors on the paper are Kazuishi Kubota, PhD, and Steven P. Gygi, PhD, of Harvard Medical School, and Elaine Lunsford and John V. Frangioni, MD, PhD, of Beth Israel Deaconess Medical Center.
The research was supported by grants from the National Institutes of Health and the Picower Foundation.
Dana-Farber Cancer Institute (www.dana-farber.org) is a principal teaching affiliate of the Harvard Medical School and is among the leading cancer research and care centers in the United States. It is a founding member of the Dana-Farber/Harvard Cancer Center (DF/HCC), designated a comprehensive cancer center by the National Cancer Institute.
Bill Schaller | Newswise Science News
Study tracks inner workings of the brain with new biosensor
16.08.2018 | Rheinische Friedrich-Wilhelms-Universität Bonn
Foods of the future
15.08.2018 | Georg-August-Universität Göttingen
New design tool automatically creates nanostructure 3D-print templates for user-given colors
Scientists present work at prestigious SIGGRAPH conference
Most of the objects we see are colored by pigments, but using pigments has disadvantages: such colors can fade, industrial pigments are often toxic, and...
Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...
Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.
When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...
Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.
Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....
Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.
Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...
17.08.2018 | Event News
08.08.2018 | Event News
27.07.2018 | Event News
17.08.2018 | Physics and Astronomy
17.08.2018 | Information Technology
17.08.2018 | Life Sciences